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Larynx is extremely sensitive to endocrinologic changes. 
Most vocal fold mucosa alterations are caused by changes in 
vocal fold liquid content and its epithelial changes. Estrogen 
and progesterone interfere and change this liquid content in 
the vocal folds. Our goal with the present paper is to study 
the presence of estrogen and progesterone receptors on vocal 
fold epithelium in 19 vocal fold epithelium specimens that did 
not present any indication of disease, especially inflammatory 
disease. We discarded those cases of patients above 40 years 
of age and those below 15. Results: we found progesterone 
receptors in 18 of the 19 patients. The progesterone receptors 
are located both in the nucleus and the cytoplasm of cells, 
and mainly in the basal layer. There was no report of estrogen 
receptors present in the vocal folds. Conclusion: Vocal fold 
epithelium bears progesterone receptors, in the cytoplasm 
and in the nucleus. We did not find estrogen receptors in 
the epithelia of the vocal folds investigated. 
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INTRODUCTION
Hormones are molecules secreted onto the blood 
current that usually have their biological effect in sites 
away from where they were produced. They cause growth, 
differentiation and functionality in different target organs. 
Hormones effect on target organs is due to their bindings 
with intracellular receptors, modulating gene expression 
and, consequently, the synthesis of specific proteins1.
Hormonal receptors are being currently investiga-
ted in almost all anatomical regions, such as the breast, 
bones, testicles, brain, lacrimal glands, heart, ovaries, 
endometrium, among others2. Despite all of this, the in-
teraction between the endocrine system and the larynx is 
surprisingly not studied enough, even knowing of the great 
susceptibility the larynx has towards hormonal effects3.
Such interaction is proven by clinical and empirical 
events that occur in the larynx, such as voice change, 
pre-menstrual syndrome and vocal alterations during 
menopause.
The effects of sex hormones is clearly seen in voi-
ce change, when there is a differentiation between male 
and female voices, and when a kid’s voice turns into an 
adult’s voice4. Menstruation may prevent people who 
have their voice as a working tool to sing, because in 
the days immediately before menstruation and ovulation, 
hormonal alterations interfere in their voices5. During this 
period, female singers are encouraged by conductors and 
singing tutors not to perform, because of a drop in voice 
quality6.
Based on these clinical observations, some resear-
chers such as Abitbol et al.7 and Caruso et al.8 used cytology 
studies to assess the alterations hormones would cause 
to vocal cords. These authors noticed that cell alterations 
that happened in the uterus cervix during the menstrual 
cycle were the same ones that happened on the vocal 
cord mucosa, following the different hormonal actions of 
estrogen and progesterone. They showed that in fact, vocal 
fold epithelium may suffer the action of sex hormones. 
Abitbol et al.7 did their study before, during and after the 
menstrual cycle. Caruso et al.8 studied female patients who 
were in menopause and had atrophy of their uterine cervix 
and vocal cords before and after hormonal replacement 
therapy. These cell studies on the action of sex hormones 
in the larynx were the necessary basis for the next studies 
about hormonal receptors in vocal cords.
There are only two papers that approach hormone 
presence in vocal cords: Piatkowski et al.9 used immu-
nohistochemistry to study the presence of estrogen and 
progesterone receptors in the larynx of patients with cancer 
and in normal individuals. Hormone receptors were not 
found in the vocal cords, but rather in the supraglottic re-
gion. Newman et al.10 also studied estrogen, progesterone 
and testosterone receptors in vocal cords. The study was 
carried out in cadavers of both genders. Progesterone and 
testosterone receptors were positive in all the cases. Only 5 
of 18 patients were positive for estrogen. These two papers 
showed that there is little estrogen receptor expression 
in the vocal cords, contrary to what was expected since 
histology studies proved large hormonal action on vocal 
cords, especially that of estrogen.
The possible ambiguity among cytology studies of 
estrogen and progesterone action on the larynx and the 
little expression of hormonal receptors on vocal cords led 
to the receptor’s research carried out in the present paper. 
The goals have been to asses the presence of estrogen 
and progesterone receptors on the epithelium of women’s 
vocal folds and differentiate their intracellular location.
MATERIALS AND METHODS
This paper has been submitted to and approved by 
the Ethics Committee of the School of Medical Sciences of 
the Santa Casa de São Paulo, protocol # 022/05.
We studied slides from patients followed at the De-
partment of Otorhinolaryngology of the School of Medical 
Sciences of the Santa Casa de São Paulo. Theses slides 
were obtained retrospectively after reviewing the charts of 
patients who had previously undergone vocal cord surgery 
from January through December of 1999.
The slides chosen presented normal epithelium, 
and those that had some acute or chronic inflammatory 
process were discarded.
We also excluded from the study, the slides from 
patients above 40 years of age and below 15 years old. 
The slides selected bore the following problems: 
mucous bridge (one case), submucosal cyst (13 cases), 
hemangioma (one case), bridle (two cases) and larynx 
biopsy (two cases).
The slides selected were histologically evaluated 
embedded in paraffin and fixed in formalin. The specimens 
were then sectioned at a thickness of 5 to 6mm. The cross 
sections were then hydrated, had the paraffin removed 
were and embedded in a 0.01 mols/L saline buffer in pH 
of 7.4 and treated with 0.1% trypsin for 30 minutes at 37ºC. 
The specimens were covered with hydrogen peroxide for 
5 minutes and after that were incubated separately with 
primary estrogen and progesterone antibodies, during 
one night, at 4ºC. The reaction was developed with dia-
minobezidine at room temperature for 10 minutes and, 
after that, the procedure was repeated for the secondary 
antibodies. Immunoreactiveness was studied under light 
microscopy.
The following primary antibodies were used: 
Estrogen Receptor Antibodies Lyophilized Monoclonal 
(NCL-ER-6f11) and the Progesterone Receptor Antibodies 
Lyophilized Monoclonal (NCL-PGR-312) from Novocastra. 
The secondary antibody used was the Strept complex. 
ABComplex/HRP, Rabbit/Mouse (code k0492) from Biogen 
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(DAKO). The slides were dyed with hematoxylin eosin 
after the use of antibodies.
The slides were studied according to the positive-
ness of estrogen and progesterone receptors and their pre-
sence was verified as to its intracellular location (nucleus 
or cytoplasm). Data was statistically evaluated by means 
of the 95% confidence interval.
RESULTS
We found 19 cases of normal vocal cord epithelium 
for the study of estrogen and progesterone receptors.
1-Age
Patients’ ages varied between 25 and 34 years. Mean 
age was of 31.58 years.
2- Estrogen
We did not find estrogen receptors on the vocal 
cords epithelium, both in the cytoplasm and in the cell 
nucleus.  Lack of estrogen p= (0/19) =0; p<0.0000001.
3- Progesterone
Progesterone was positive in 18 of the 19 cases 
studied in the epithelium of the vocal folds. The presence 
of progesterone was of p = (18/19) = p=0.952; p<0.05. 
The only negative case came from a bridle on the vocal 
Figure 1. Vocal fold without immunohistochemistry - Figure 2. LM.HE 
318x. Vocal fold cross-section immediately anterior to that of Figure 1, 
without the use of immunohistochemistry.
Figure 2. Progesterone positive - Figure 1. LM. HE. 318x. Vocal fold 
cross-section showing progesterone receptors. Positiveness is seen 
by means of this red-brownish dye.
cords. The remaining cases: mucous bridge (one case), 
submucosal cyst (13 cases), hemangioma (one case), 
bridle (one case) and larynx biopsy (two cases) were 
progesterone positive.
a) Location in the epithelium: the 18 positive cases 
were studied as to their epithelial location: basal layer or 
intermediate zone. In order to do that, we counted the 
basal layer cells in a visual field that had the reagent and 
the cells which were not dyed. Of the 18 cases studied, 
we noticed that only 4.34% of the cells were not positive. 
In the intermediate layer, there was a less standardized 
pattern, negative in 3 cases, with one or two positive cells 
in 13 cases and in two cases of total positiveness, with 
only 2 cells in one slide that was not positive and 3 cells 
which were not positive in another slide (Pictures 1, 2, 
3 and 4).
Picture 1) LM.HE. (318x) Positive for the progestero-
ne receptor (notice the brownish color). 2) LM.HE. (318x) 
vocal fold, showing an immediately anterior cross-section, 
without dye in order to assess progesterone positiveness 
(bluish color).3) LM. (63x) HE. Normal vocal fold epi-
thelium, negative for estrogen receptor. 4) MO.HE. (63x) 
Normal vocal fold epithelium, positive for progesterone 
receptor. Notice the brown color of the vocal fold epi-
thelium.
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b) Intracellular location (Nucleus x Cytoplasm)
All 18 positive cases had receptors in their cell nu-
clei. Cytoplasm was positive in 16 of the 18 cases. 
clearly superior to the ligandin test12.
  As to age, we excluded menopause patients, and 
we considered only those patients above 40 years of age. 
At menopause there is less estrogen, progesterone and 
testosterone hormone expression13. Such behavior could 
influence results in this study group, and their exclusion 
was necessary for statistics sake.
Patients below 15 years of age were also excluded. 
Hormonal receptors’ behavior at this age range is marke-
dly different. It is believed that the number of receptors in 
the pre-pubertal phase be higher when compared to any 
other age. Clinically, we observe in males that estrogen 
use in the fetal or neonatal period may cause reproduc-
tive disorders such as cryptorquism, epididymal defects, 
infertility, and increase in testicle cancer incidence14. In 
females, menarche is of genetic origin; it is influenced by 
sex hormones and mediated through estrogen receptors15. 
Such genomic action is more intense in the pre-pubertal 
period, and this fact could impact our results. 
Piatkowski et al.9 and Newman et al.10 did not 
consider age in their studies. They included all patients, 
even those below 15 years and those after menopause. 
Piatkowski et al.9 also included all patients in their study 
group, as a matter of fact, all their patients were above 
45 years of age. This may very well be one of the reasons 
as to why they did not find estrogen, progesterone or 
testosterone receptors in the vocal folds. The presence of 
estrogen receptors in Newman et al.’s investigation10 was 
positive only for those patients below 15 years of age, 
including patients in these two age ranges, when there is 
marked hormonal changes, may account for the different 
results and be a bias factor in these two investigations. 
In our study, the disorder diagnosis did not impact 
results. Diagnosis: mucosal bridge, submucosal cyst, 
submucosal hemangioma and biopsy did not interfere 
in the results attained. The only case in which we did 
not have positiveness was for bridle, and the epithelium 
was normal. 
In our investigation we did not find estrogen re-
ceptors. Such result was also negative for Piatkowski et 
al.9. Newman et al. found positiveness in only five of the 
18 cases studied10. Alpha (Eα) and beta (Eβ)16 estrogen 
receptors were jointly investigated in our study, since 
we were not interested in their differentiation. The alpha 
estrogen receptor has a greater predisposition for the de-
velopment of malignant tumors; and as for the beta (Eβ), 
there is a greater likelihood of the person developing 
pre-malignant lesions.
Results from Piatkowski et al.9 and Newman et 
al.10 are in disagreement in relation to a cytology paper 
published by Abitbol et al.7 and Caruso et al.8, who sho-
wed a relevant estrogen presence. 
Figure 3. Negative for estrogen receptors - Figure 3. LM. (63x) HE. 
Normal vocal fold epithelium; negative for estrogen receptors.
Figure 4. Positive for progesterone receptors - Figure 4. MO.HE.(63x) 
Normal vocal fold epithelium; positive for progesterone receptors. 
Notice the brownish color of the vocal fold epithelium.
DISCUSSION
The results presented in this paper show that sex 
hormones do act in the vocal folds; however, in a different 
way. These characteristics may be important in unders-
tanding and treating different larynx disorders. 
In the present investigation, the research was 
carried out by immunohistochemistry, which was used 
because it is a typical tumoral maker11, since it bears high 
sensitivity and allows morphological tissue evaluation. 
It is also a semi-quantitative test, bearing lower costs 
that the ligandin binding test, and it is easier in slide 
handling. It also marks cell development lineages and 
requires less fresh tissue to be carried out11. Until 1990’s, 
estrogen receptors investigation was carried out by the 
ligandin binding text in fresh tissue. More recently, im-
munohistochemistry has become the method of choice 
to determine the presence of such receptors, since it is 
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Caruso et al.8 studied menopause women who had 
not undergone hormonal replacement therapy. In their 
vocal fold epithelium there were signs of atrophy and 
dystrophy before treatment. After hormonal replacement, 
these signs disappeared. The use of medication caused 
epithelial atrophy normalization, both in the uterine cer-
vix and in the larynx, thus proving the estrogen action 
in the vocal folds. 
Abitbol et al.7 found epithelial changes in the vocal 
folds and in the uterine cervix in all phases of menstru-
ation, proving that the larynx is an organ that responds 
to hormonal changes in each one of the menstrual cycle 
phases. 
Based on these data, we may deduct that there is 
estrogen action in the larynx; however, such action may 
not be present in this epithelium as previously believed. 
These receptors may be located in other sites such as the 
vocal fold muscles. It is known that the inner portion of 
the thyroarytenoid muscle is the major site of androgenic 
hormonal action17, this could also be the action site for 
estrogen. Wu et al. noticed that estrogen receptors may 
be present in neuromuscular synapses present in larynx 
intrinsic muscles18.
Piatkowski et al.9 noticed that hormonal receptors 
are preferentially present in the supraglottic region. 
Such region bears a number of glands implicated in the 
production of laryngeal secretions. These hormone-rich 
secretions could soak the vocal folds and cause the alte-
rations seen in these cytology studies.
Another factor to be considered is that proges-
terone receptors inhibit their estrogenic counterparts19. 
In our study, we saw positiveness for progesterone re-
ceptors in 18 of the 19 patients investigated. By means 
of self-regulation mechanisms, estrogen receptors have 
their presentation blocked. On the other hand, estrogen 
receptors may indeed be lacking in the vocal folds, as it 
is seen in other organs, such as the liver20.
As far as progesterone is concerned, there was po-
sitiveness in 18 of the 19 cases, representing their impor-
tant presence in the vocal folds epithelium, in agreement 
with the results found by Newman et al.10, who found a 
relevant presence of progesterone receptors in the vocal 
folds. Contrary to that, Piatkowski et al.9 did not find pro-
gesterone receptors in the vocal folds. As it happened to 
the estrogen receptors, the aforementioned author did not 
find positiveness for progesterone in their patients above 
54 years. They would include menopause patients, who 
have a lower progesterone receptor expression. 
In almost all organs, progesterone receptors are the 
main structures responsible for commanding cell activity, 
including the endometrial glands, where estrogen and 
progesterone act in a synergic fashion21. This marked 
progesterone action is caused by its direct action on 
cell nuclei transcription, the main cell activity command 
center22.
In our investigation we studied progesterone pre-
sence in both the nucleus and the cytoplasm. The test 
was positive in the nuclei for all the cases; and it was 
only in 3 of the 18 cases that it was not positive in the 
cytoplasm. The goal in differentiating between nuclei 
and cytoplasm is that these two types of receptors have 
different behavior22. The receptors located in the nucleus 
are able to modulate the hormones, inhibiting or stimula-
ting them, and thus, controlling their different functions 
in the different body tissues; therefore, controlling their 
different functions in the different body tissues; thus, 
commanding the different physiologic effects23. The so 
called non-nuclear cytoplasmic action is related to the 
quick vasodilatation and vascular response inhibition 
towards tissue damage23.
In our study we found progesterone receptor 
dominance in the epithelial basal layer. This layer is the 
one with the most proliferative activity. This proliferative 
activity was noticed by Van Cruchten24 in the epithelium 
of dogs and was related to progesterone activity. This 
progesterone-induced proliferative activity was present 
with an increase in mitotic activity, angiogenesis and 
crypts. Nogushi et al.25 noticed intense progesterone-
induced extracellular matrix production activity from the 
basal cell layer. Since extracellular matrix production and 
epithelium proliferative activity are conditions present 
in both the normal and pathological larynx activity, this 
progesterone action in the basal layer has to be better 
investigated. 
The clinical importance of our findings here is 
that progesterone can cause vasodilatation, hemorrhage 
and alterations in the epithelial surface lubrication26. Sex 
hormones are implicated in the aquaporin channel regula-
tion27, which are a family of proteins from cell membrane 
channels that facilitate water transport27. Thus, proges-
terone is one of the most important factors in regulating 
epithelial surface lubrication, since water output from 
the epithelium is directly related to its presence. It has 
been proven that in patients with dysphonia caused by 
stress and tiredness of the vocal folds, there is symptoms’ 
worsening because of an increase in mucous viscosity; 
increase in mucous aggregation and also by the rough-
ness on vocal fold surface28. Larynx mucous viscosity 
influences vocal fold vibration28. Nakagawa et al.29 applied 
fluids of different viscosities on the vocal folds of dogs 
and noticed that the higher the viscosity, the less is vocal 
fold range of vibration and smaller glottic contact area, 
thus affecting vocal fold surface movement. Knowledge 
about aquaporins is already being used for the treatment 
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cerebral edema with progesterone (Guo et al.)30.
By the results found in the present investigation, 
we believe the larynx is a target for progesterone action, 
as far as vascular action is concerned. During the mens-
trual cycle, new capillaries are created from the already 
existing microvasculature. These new capillaries suffer 
maturation and remodeling, forming a new vascular ne-
twork at each cycle. (Albrecht and Pepe)31. Kayisle et al.32 
stated that blood vessel growth and regression are regula-
ted by sex hormones through the menstrual cycle and the 
major agent responsible for this angiogenic proliferation 
is progesterone and estradiol. Another investigation found 
unequivocally the presence of progesterone receptors in 
the vessels of many different tissues, including the pla-
centa, where progesterone is the major factor involved 
in angiogenesis (Cudeville et al.)33.
The knowledge acquired by the present investi-
gation regarding sex hormonal action on the larynx is 
essential in understanding the different larynx disorders. 
Hormones affect the larynx in different ways, especially 
sex steroids, and must be always assessed when one has 
a patient with vocal complaints, and should be part of the 
therapeutic arsenal of all otorhinolaryngologists. 
CONCLUSION
Progesterone receptors are present in the basal 
layer of the vocal fold epithelium and are located in cell 
nucleus and cytoplasm. Estrogen receptors were not 
present in vocal fold epithelium. 
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